However, siRNA mediated RUNX2 ablation does not completely abolish the TGF-β effect on CDH6 expression suggesting that other TGF-β–dependent factors beside RUNX2 may be involved in controlling this gene in thyroid tumor cells. This evidence concerns the gene TGFB1 and thyroid tumor.